Newsletter Readout: Kailera, Zepbound, Cerra, Biolabs

Do you want to stay at the top of science and politics to conduct biotechnology today? Register to get our Biotech newsletter in your reception box.

Good morning. We have a short and soft newsletter today. And if you are in areas struck by flash foods, I hope you stay safe.

A laboratory pioneer fears that the American industry will lose its advantage

Johannes Fruehauf, founder of Labcentral and Biolabs laboratory real estate companies, is increasingly turning to Europe – and even Saudi Arabia – while American policies cloud the future of biotechnology in the United States.